Wiki-Pi

Search Results for: Schizophrenia

1632 interactions found:

Sort by: Relevance Number of Pathways Number of Drugs Number of Diseases
Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
ROBO2 and OLFM2 roundabout, axon guidance receptor, homolog 2 (Drosophila) olfactomedin 2
  • Axon guidance
  • Regulation of Commissural axon pathfinding by Slit and Robo
  • Signaling by Robo receptor
ROBO2 and SLIT3 roundabout, axon guidance receptor, homolog 2 (Drosophila) slit homolog 3 (Drosophila)
  • Axon guidance
  • Regulation of Commissural axon pathfinding by Slit and Robo
  • Signaling by Robo receptor
  • Axon guidance
  • Netrin-1 signaling
ROBO2 and UBQLN4 roundabout, axon guidance receptor, homolog 2 (Drosophila) ubiquilin 4
  • Axon guidance
  • Regulation of Commissural axon pathfinding by Slit and Robo
  • Signaling by Robo receptor
ROBO2 and TRIM13 roundabout, axon guidance receptor, homolog 2 (Drosophila) tripartite motif containing 13
  • Axon guidance
  • Regulation of Commissural axon pathfinding by Slit and Robo
  • Signaling by Robo receptor
  • Etorphine
  • Diprenorphine
  • Dihydromorphine
RORA and NCOA2 RAR-related orphan receptor A nuclear receptor coactivator 2
  • PPARA activates gene expression
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • REV-ERBA represses gene expression
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • RORA activates circadian gene expression
  • PPARA activates gene expression
  • Bile acid and bile salt metabolism
  • Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)
  • Organelle biogenesis and maintenance
  • Metabolism of lipids and lipoproteins
  • Metabolic disorders of biological oxidation enzymes
  • Phase 1 - Functionalization of compounds
  • Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)
  • RORA activates circadian gene expression
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)
  • Generic Transcription Pathway
  • Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)
  • Cytochrome P450 - arranged by substrate type
  • Endogenous sterols
  • Transcriptional regulation of white adipocyte differentiation
  • Biological oxidations
  • Synthesis of bile acids and bile salts
  • Orphan transporters
  • Defective FMO3 causes Trimethylaminuria (TMAU)
  • Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)
  • Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)
  • Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)
  • Recycling of bile acids and salts
  • Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)
  • REV-ERBA represses gene expression
  • Defective CYP1B1 causes Glaucoma
  • Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)
  • Mitochondrial biogenesis
  • Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)
  • Defective CYP19A1 causes Aromatase excess syndrome (AEXS)
  • Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)
  • Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)
  • Synthesis of bile acids and bile salts via 27-hydroxycholesterol
  • Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
  • Defective MAOA causes Brunner syndrome (BRUNS)
  • Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)
  • YAP1- and WWTR1 (TAZ)-stimulated gene expression
  • Activation of gene expression by SREBF (SREBP)
  • Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • Transcriptional activation of mitochondrial biogenesis
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
RORA and ZXDC RAR-related orphan receptor A ZXD family zinc finger C
  • PPARA activates gene expression
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • REV-ERBA represses gene expression
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • RORA activates circadian gene expression
RORA and NCOA1 RAR-related orphan receptor A nuclear receptor coactivator 1
  • PPARA activates gene expression
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • REV-ERBA represses gene expression
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • RORA activates circadian gene expression
  • PPARA activates gene expression
  • Bile acid and bile salt metabolism
  • Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)
  • Organelle biogenesis and maintenance
  • Metabolism of lipids and lipoproteins
  • Metabolic disorders of biological oxidation enzymes
  • Phase 1 - Functionalization of compounds
  • Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)
  • RORA activates circadian gene expression
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)
  • Generic Transcription Pathway
  • Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)
  • Cytochrome P450 - arranged by substrate type
  • Endogenous sterols
  • Transcriptional regulation of white adipocyte differentiation
  • Biological oxidations
  • Synthesis of bile acids and bile salts
  • Orphan transporters
  • Defective FMO3 causes Trimethylaminuria (TMAU)
  • Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)
  • Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)
  • Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)
  • Recycling of bile acids and salts
  • Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)
  • REV-ERBA represses gene expression
  • Defective CYP1B1 causes Glaucoma
  • Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)
  • Mitochondrial biogenesis
  • Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)
  • Defective CYP19A1 causes Aromatase excess syndrome (AEXS)
  • Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)
  • Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)
  • Synthesis of bile acids and bile salts via 27-hydroxycholesterol
  • Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
  • Defective MAOA causes Brunner syndrome (BRUNS)
  • Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)
  • YAP1- and WWTR1 (TAZ)-stimulated gene expression
  • Activation of gene expression by SREBF (SREBP)
  • Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • Transcriptional activation of mitochondrial biogenesis
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
RORA and SMARCD3 RAR-related orphan receptor A SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3
  • PPARA activates gene expression
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • REV-ERBA represses gene expression
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • RORA activates circadian gene expression
  • PPARA activates gene expression
  • Organelle biogenesis and maintenance
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Chromatin organization
  • REV-ERBA represses gene expression
  • RORA activates circadian gene expression
  • Mitochondrial biogenesis
  • RMTs methylate histone arginines
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Chromatin modifying enzymes
  • Generic Transcription Pathway
  • Transcriptional regulation of white adipocyte differentiation
  • YAP1- and WWTR1 (TAZ)-stimulated gene expression
  • Activation of gene expression by SREBF (SREBP)
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • Transcriptional activation of mitochondrial biogenesis
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • Orphan transporters
RORA and COPS5 RAR-related orphan receptor A COP9 signalosome subunit 5
  • PPARA activates gene expression
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • REV-ERBA represses gene expression
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • RORA activates circadian gene expression
RORA and PNRC1 RAR-related orphan receptor A proline-rich nuclear receptor coactivator 1
  • PPARA activates gene expression
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • REV-ERBA represses gene expression
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • RORA activates circadian gene expression
RORA and LRIF1 RAR-related orphan receptor A ligand dependent nuclear receptor interacting factor 1
  • PPARA activates gene expression
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • REV-ERBA represses gene expression
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • RORA activates circadian gene expression
RORA and PNRC2 RAR-related orphan receptor A proline-rich nuclear receptor coactivator 2
  • PPARA activates gene expression
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • REV-ERBA represses gene expression
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • RORA activates circadian gene expression
RORA and NSD1 RAR-related orphan receptor A nuclear receptor binding SET domain protein 1
  • PPARA activates gene expression
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • REV-ERBA represses gene expression
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • RORA activates circadian gene expression
  • Chromatin modifying enzymes
  • Chromatin organization
  • PKMTs methylate histone lysines
RORA and EIF3I RAR-related orphan receptor A eukaryotic translation initiation factor 3, subunit I
  • PPARA activates gene expression
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • REV-ERBA represses gene expression
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • RORA activates circadian gene expression
  • Ribosomal scanning and start codon recognition
  • Translation initiation complex formation
  • Formation of the ternary complex, and subsequently, the 43S complex
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Translation
  • Eukaryotic Translation Initiation
  • Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
  • Formation of a pool of free 40S subunits
  • Cap-dependent Translation Initiation
  • L13a-mediated translational silencing of Ceruloplasmin expression
RORA and LMO3 RAR-related orphan receptor A LIM domain only 3 (rhombotin-like 2)
  • PPARA activates gene expression
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • REV-ERBA represses gene expression
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • RORA activates circadian gene expression
RPGR and IFT88 retinitis pigmentosa GTPase regulator intraflagellar transport 88
  • Organelle biogenesis and maintenance
  • Hedgehog 'off' state
  • Signaling by Hedgehog
  • Assembly of the primary cilium
  • Intraflagellar transport
RPL27 and NRP1 ribosomal protein L27 neuropilin 1
  • Nonsense-Mediated Decay (NMD)
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Signal transduction by L1
  • CHL1 interactions
  • Axon guidance
  • Semaphorin interactions
  • Signaling by VEGF
  • Sema3A PAK dependent Axon repulsion
  • Neurophilin interactions with VEGF and VEGFR
  • L1CAM interactions
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • CRMPs in Sema3A signaling
RXRA and HDAC4 retinoid X receptor, alpha histone deacetylase 4
  • Bile acid and bile salt metabolism
  • Metabolism of lipids and lipoproteins
  • Nuclear Receptor transcription pathway
  • Metabolic disorders of biological oxidation enzymes
  • Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)
  • Generic Transcription Pathway
  • Endogenous sterols
  • Synthesis of bile acids and bile salts
  • Orphan transporters
  • Defective FMO3 causes Trimethylaminuria (TMAU)
  • Signaling by Retinoic Acid
  • Recycling of bile acids and salts
  • Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)
  • Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)
  • Defective CYP19A1 causes Aromatase excess syndrome (AEXS)
  • Regulation of pyruvate dehydrogenase (PDH) complex
  • Pyruvate metabolism
  • Synthesis of bile acids and bile salts via 27-hydroxycholesterol
  • Defective MAOA causes Brunner syndrome (BRUNS)
  • Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)
  • Activation of gene expression by SREBF (SREBP)
  • The citric acid (TCA) cycle and respiratory electron transport
  • Transcriptional activation of mitochondrial biogenesis
  • PPARA activates gene expression
  • Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)
  • Organelle biogenesis and maintenance
  • Import of palmitoyl-CoA into the mitochondrial matrix
  • Pyruvate metabolism and Citric Acid (TCA) cycle
  • Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)
  • Phase 1 - Functionalization of compounds
  • RORA activates circadian gene expression
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)
  • Cytochrome P450 - arranged by substrate type
  • Transcriptional regulation of white adipocyte differentiation
  • Biological oxidations
  • Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)
  • Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)
  • Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)
  • REV-ERBA represses gene expression
  • Defective CYP1B1 causes Glaucoma
  • Mitochondrial biogenesis
  • Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)
  • Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)
  • Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)
  • Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
  • Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)
  • YAP1- and WWTR1 (TAZ)-stimulated gene expression
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Signaling by NOTCH
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by NOTCH1
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • FBXW7 Mutants and NOTCH1 in Cancer
  • Adapalene
  • Bexarotene
  • Acitretin
  • Alitretinoin
  • Etodolac
  • Etretinate
  • (5BETA)-PREGNANE-3,20-DIONE
  • 2-chloro-5-nitro-N-phenylbenzamide
  • 1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE
  • 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID
  • tributylstannanyl
S100A4 and BAG6 S100 calcium binding protein A4 BCL2-associated athanogene 6
ATXN1 and ZNF804A ataxin 1 zinc finger protein 804A

Page 48 out of 82 pages